Literature DB >> 23749273

Bacteriophages in gut samples from pediatric Crohn's disease patients: metagenomic analysis using 454 pyrosequencing.

Josef Wagner1, Jovana Maksimovic, Gabriella Farries, Winnie H Sim, Ruth F Bishop, Donald J Cameron, Anthony G Catto-Smith, Carl D Kirkwood.   

Abstract

BACKGROUND: The role of bacteriophage in Crohn's disease (CD) is unknown. This study investigated the abundance of phages in ileal and colonic samples from pediatric CD patients and controls.
METHODS: Ileal and colonic biopsies from 6 CD patients, gut wash samples from 3 CD patients, and ileal biopsies from 6 noninflammatory bowel disease patients (controls) were analyzed for the presence of bacteriophage using 454 high-throughput pyrosequencing. A sequence-independent single-primer amplification method was used to amplify viral sequences.
RESULTS: A total of 186,143 high quality reads were obtained from the 4 sample populations. Contigs and sequence clusters (generated from unassembled singletons) were aligned with sequences from the National Center for Biotechnology Information viral reference database and analyzed by MEGAN. The largest number of viral hits was obtained from the CD gut wash samples (n = 691), followed by CD ileal samples (n = 52), control ileum samples (n = 20), and CD colonic samples (n = 1). The most abundant virus sequences identified belonged to the Caudovirales phage.
CONCLUSIONS: Our study characterized a diverse phage community in the gut of CD patients. In this study, we have identified differences in phage composition between CD patients and control individuals. The large abundance of phages in CD ileum tissue and CD gut wash sample suggests a role of phage in CD development. The role of phage dysbiosis in CD is currently unknown but opens up a new area of research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23749273     DOI: 10.1097/MIB.0b013e318292477c

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  65 in total

Review 1.  Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.

Authors:  Janka Babickova; Roman Gardlik
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 2.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 4.  Novel perspectives on therapeutic modulation of the gut microbiota.

Authors:  Justin L McCarville; Alberto Caminero; Elena F Verdu
Journal:  Therap Adv Gastroenterol       Date:  2016-04-04       Impact factor: 4.409

5.  Metagenomics analysis of the gut microbiome in healthy and bacterial pneumonia forest musk deer.

Authors:  Wei Zhao; Ziwei Ren; Yan Luo; Jianguo Cheng; Jie Wang; Yin Wang; Zexiao Yang; Xueping Yao; Zhijun Zhong; Wei Yang; Xi Wu
Journal:  Genes Genomics       Date:  2021-01-11       Impact factor: 1.839

6.  Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches.

Authors:  Jonathan J Hansen; R Balfour Sartor
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

Review 7.  Gut microbiota and IBD: causation or correlation?

Authors:  Josephine Ni; Gary D Wu; Lindsey Albenberg; Vesselin T Tomov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-19       Impact factor: 46.802

8.  Disease-specific alterations in the enteric virome in inflammatory bowel disease.

Authors:  Jason M Norman; Scott A Handley; Megan T Baldridge; Lindsay Droit; Catherine Y Liu; Brian C Keller; Amal Kambal; Cynthia L Monaco; Guoyan Zhao; Phillip Fleshner; Thaddeus S Stappenbeck; Dermot P B McGovern; Ali Keshavarzian; Ece A Mutlu; Jenny Sauk; Dirk Gevers; Ramnik J Xavier; David Wang; Miles Parkes; Herbert W Virgin
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

Review 9.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

Review 10.  Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Authors:  Justin D Glenn; Ellen M Mowry
Journal:  J Interferon Cytokine Res       Date:  2016-05-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.